Infection Control: CRE Management in Pediatric Healthcare Setting

This presentation outlines a research project focused on Carbapenem-resistant Enterobacteriaceae (CRE) infection control within a healthcare setting, specifically at Boston Children's Hospital. The project aims to assess hospital monitoring processes, detail infant management during treatment, and educate pediatric care professionals through a workshop and awareness seminar. The methodology involves a survey to evaluate the seminar's effectiveness, with an estimated budget of $4000-$5000. The presentation covers data collection, risk management strategies, and an evaluation plan, concluding that the project is feasible and could improve infection control compliance. The presentation includes references to support the research and findings.

CRE INFECTION CONTROL
WITHIN HEALTHCARE SETTING
-PRESENTED BY:

INTRODUCTION:
The family of
microorganisms that
are resistant to a
broad spectrum of
antibiotics are known
as Carbapenem
resistant
enterobacteriaceae
CRE accounts for 40-
50% of the mortality
rates within a
healthcare setting
(Falagas et al., 2013) (Source:
Huttner et al.,
2013)

RESEARCH OBJECTIVES:
•To assess the routine hospital monitoring and evaluation
process towards the management of CRE.
•To outline how infants are managed during the 14 days
of the treatment period in the health care nursing facility.
•To educate and create awareness among paediatric care
professionals for the management of CRE at the health
care facility

DESCRIPTION OF THE CARE
SETTING:
The research
would take place
in the Boston
Children’s
hospital.
The project
would comprise
of conducting a
one day hands-
on workshop and
an awareness
seminar.
(Source:
Huttner et al.,
2013)

POTENTIAL SUBJECTS:
The potential
subjects or the
target audience
for the project
would comprise
of the Nurses
working within
the Infant care
unit of the
hospital.

REQUIRED RESOURCES:
The primary resources
would include the
following:
Availability of space
Availability of a physician
and an ANP for the
awareness seminar
PEP equipment
Hand wash and alcohol
rub
(Source: Wang et al., 2016)

METHODOLOGY:
The methodology that would be
undertaken for evaluation of the
effectiveness of the one day
awareness seminar and hands-
on-workshop would comprise of
collecting a survey response form
the participants.

ESTIMATED BUDGET:
The estimated budget for the
implementation of the infection
control project would be around $
4000- $5000.
The estimated budget can be
considered feasible for a one-day
project.

DATA COLLECTION:
The data collection process
would be a two-fold process.
The first set of data comprises
the respondents to the official
mail sent by the researchers who
agree to participate in the
research
The second set of data would
comprise of the collection of the
survey response forms from the

RISK-MANAGEMENT STRATEGIES:
Prior booking of the space to host
to event
Prior circulation of the notice
about the event to the
participants and the dignitaries

EVALUATION PLAN:
Stringent
monitoring of the
participants
during the event.
Analysis of the
survey data
collected at the
end of the event.

CONCLUSION:
Therefore, to conclude, it can be
expected that the research
project is extremely feasible in
terms of the estimated budget
and it could help in improving
compliance with infection control.

REFERENCES:
Cdc.gov (2019). Clinicians | HAI | CDC. [online] Cdc.gov.
Available at: https://www.cdc.gov/hai/organisms/cre/cre-
clinicians.html [Accessed 25 Feb. 2019].
Falagas, M. E., Tansarli, G. S., Karageorgopoulos, D. E., &
Vardakas, K. Z. (2014). Deaths attributable to carbapenem-
resistant Enterobacteriaceae infections. Emerging infectious
diseases, 20(7), 1170.
Huttner, A., Harbarth, S., Carlet, J., Cosgrove, S., Goossens, H.,
Holmes, A., ... & Pittet, D. (2013). Antimicrobial resistance: a
global view from the 2013 World Healthcare-Associated
Infections Forum. Antimicrobial resistance and infection
control, 2(1), 31.
Wang, Q., Zhang, Y., Yao, X., Xian, H., Liu, Y., Li, H., ... & Cao, B.
(2016). Risk factors and clinical outcomes for carbapenem-
resistant Enterobacteriaceae nosocomial infections. European
journal of clinical microbiology & infectious diseases, 35(10),
1679-1689.

THANK YOU!!